ストックスクリーナーアプリを入手
37.26
0.92%
0.3607
前日終値:
$36.90
開ける：
$36.9
24時間の取引高:
1.11M
Relative Volume:
0.33
時価総額：
$16.11B
収益：
$2.31B
当期純損益:
$1.66B
株価収益率:
16.20
EPS:
2.3
ネットキャッシュフロー:
$827.02M
1週間 パフォーマンス:
+3.50%
1か月 パフォーマンス:
-1.77%
6か月 パフォーマンス:
+10.28%
1年 パフォーマンス:
+28.10%
1日の値動き範囲:
$36.35
$37.28
1週間の範囲:
$35.86
$37.26
52週間の値動き範囲:
$24.05
$38.00
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
37.28 | 15.95B | 2.31B | 1.66B | 827.02M | 2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
398.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.44 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
570.02 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
749.19 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
338.07 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-16 | 開始されました | Morgan Stanley | Overweight |
| 2024-06-03 | ダウングレード | UBS | Buy → Neutral |
| 2022-06-14 | 再開されました | UBS | Buy |
| 2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-30 | 開始されました | Tigress Financial | Buy |
| 2020-11-09 | アップグレード | UBS | Neutral → Buy |
| 2020-07-14 | 開始されました | Evercore ISI | In-line |
| 2020-07-13 | 開始されました | BofA Securities | Buy |
| 2020-07-13 | 開始されました | Citigroup | Neutral |
| 2020-07-13 | 開始されました | Cowen | Outperform |
| 2020-07-13 | 開始されました | Goldman | Neutral |
| 2020-07-13 | 開始されました | JP Morgan | Neutral |
| 2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 開始されました | SunTrust | Buy |
| 2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
Royalty Pharma PLC $RPRX Shares Sold by AlTi Global Inc. - MarketBeat
Royalty Pharma PLC $RPRX Position Boosted by American Century Companies Inc. - MarketBeat
GMT Capital Corp Has $74.01 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
Can technical indicators confirm Royalty Pharma plc’s reversal - Newser
Ieq Capital LLC Increases Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Stock Position Increased by OMERS ADMINISTRATION Corp - MarketBeat
Strategies to average down on Royalty Pharma plcGap Up & Breakout Confirmation Trade Signals - Newser
Wall Street Zen Upgrades Royalty Pharma (NASDAQ:RPRX) to Buy - MarketBeat
Royalty Pharma to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - The Manila Times
Leading Biopharma Royalty Investor Royalty Pharma to Join Morgan Stanley Healthcare Conference Sept 9 - Stock Titan
Magnetar Financial LLC Buys Shares of 161,496 Royalty Pharma PLC $RPRX - MarketBeat
Adage Capital Partners GP L.L.C. Trims Holdings in Royalty Pharma PLC $RPRX - MarketBeat
What does recent volatility data suggest for Royalty Pharma plc2025 Geopolitical Influence & Community Verified Trade Signals - Newser
Royalty Pharma plc stock outlook for YEARDollar Strength & Low Drawdown Momentum Trade Ideas - Newser
Royalty Pharma plc stock prediction for this weekJuly 2025 Closing Moves & Free Safe Entry Trade Signal Reports - Newser
Royalty Pharma PLC $RPRX Shares Sold by Evergreen Capital Management LLC - MarketBeat
Is Royalty Pharma plc a candidate for recovery playJuly 2025 Trade Ideas & Smart Swing Trading Techniques - Newser
Short interest data insights for Royalty Pharma plcM&A Rumor & Low Risk Entry Point Tips - Newser
Walleye Capital LLC Has $354,000 Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc stock volume spike explainedQuarterly Profit Review & Verified Momentum Watchlists - Newser
What Fibonacci levels say about Royalty Pharma plc reboundPrice Action & Weekly Market Pulse Alerts - Newser
Using economic indicators to assess Royalty Pharma plc potentialJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser
Royalty Pharma plc stock trendline breakdownCEO Change & High Win Rate Trade Tips - Newser
Will Royalty Pharma plc benefit from macro trendsJuly 2025 Outlook & Long-Term Safe Investment Ideas - Newser
Combining machine learning predictions for Royalty Pharma plcMarket Activity Summary & Daily Entry Point Trade Alerts - Newser
Will Royalty Pharma plc stock recover after recent drop2025 Volatility Report & Growth Focused Entry Point Reports - Newser
How to recover losses in Royalty Pharma plc stockDollar Strength & Weekly Setup with ROI Potential - Newser
Is Royalty Pharma plc currently under institutional pressure2025 Pullback Review & Long-Term Investment Growth Plans - khodrobank.com
Compound Planning Inc. Acquires New Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Is Royalty Pharma plc stock forming a cup and handleJuly 2025 Action & Free High Accuracy Swing Entry Alerts - khodrobank.com
Is Royalty Pharma plc still worth holding after the dipQuarterly Performance Summary & Accurate Technical Buy Alerts - Newser
How to monitor Royalty Pharma plc with trend dashboardsQuarterly Earnings Report & Expert Curated Trade Ideas - Newser
Royalty Pharma PLC $RPRX Shares Sold by BNP Paribas Financial Markets - MarketBeat
Royalty Pharma PLC $RPRX Shares Sold by Canada Pension Plan Investment Board - MarketBeat
Applying sector rotation models to Royalty Pharma plcRecession Risk & Long-Term Capital Growth Strategies - Newser
Will Royalty Pharma plc benefit from AI trends2025 Volatility Report & Capital Protection Trading Alerts - khodrobank.com
Royalty Pharma prices $2 billion senior unsecured notes offering - StreetInsider
Is a relief rally coming for Royalty Pharma plc holders2025 Market WrapUp & Safe Entry Point Identification - Newser
Royalty Pharma Prices $2 Billion Debt Offering - MarketScreener
Zenas BioPharma secures $300M funding from Royalty Pharma for obexelimab royalties. - AInvest
Royalty Pharma plc Announces Pricing of $2.0 Billion of Senior Unsecured Notes - MarketScreener
Is Royalty Pharma plc forming a reversal patternMarket Risk Summary & Weekly High Potential Stock Alerts - Newser
Technical signs of recovery in Royalty Pharma plc2025 Big Picture & Free Safe Capital Growth Stock Tips - Newser
How to interpret RSI for Royalty Pharma plc stockJuly 2025 Review & Fast Gaining Stock Reports - Newser
Royalty Pharma prices $2B senior unsecured notes - MSN
Applying Wyckoff theory to Royalty Pharma plc stockGlobal Markets & Real-Time Buy Zone Alerts - Newser
Will breakout in Royalty Pharma plc lead to full recovery2025 Analyst Calls & Fast Entry High Yield Stock Tips - Newser
Can Royalty Pharma plc expand its profit marginsJuly 2025 Final Week & Safe Capital Growth Trade Ideas - khodrobank.com
Royalty Pharma plc recovery potential after sell offEarnings Recap Report & Fast Gain Stock Trading Tips - Newser
Royalty Pharma Prices $2 Bln Offering Of Senior Unsecured Notes - Nasdaq
Royalty Pharma Announces Pricing of $2.0 Billion of Senior Unsecured Notes - The Manila Times
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
0.23%
0.69%
大文字化:
|
ボリューム (24 時間):